1. Medtech Insight
  2. >>Policy & Regulation

GAO: Self-Referrals For Advanced Imaging Cause Medicare Costs To Rise

A Government Accountability Office report recommends CMS take direct measures to reduce Medicare spending on self-referred imaging services, but the Medicare agency is not on board with most of GAO’s ideas.

Physicians who self-referred patients for advanced imaging services accounted for notably more growth in utilization and spending for these services by Medicare between 2004 and 2010 than doctors who referred patients for imaging at practices in which they had no financial interest, according to an Oct. 31 Government Accountability Office report.

As a result of its investigation, GAO recommends CMS take direct measures to reduce Medicare spending on self-referred imaging services,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Medtech Insight

US FDA Unveils Plans To Consolidate Support Services

 
• By Derrick Gingery and Sue Sutter

Commissioner Martin Makary told staff that plans are being developed to centralize HR, IT, travel and other functions, which were heavily impacted by the 1 April reduction-in-force.

A Year After Exiting The Ventilator Market, Medtronic Recalls Thousands Of Newport Devices

 
• By Brian Bossetta

After two serious injuries and one death linked to some of its ventilators, Medtronic has recalled the devices and asked customers to stop using them and find alternative means. The action comes more than a year after the company left the market.

‘UK Must Put Adoption On A Par With Innovation’

 
• By Ashley Yeo

Market access concerns dominated at the annual BioWales In London event, where AstraZeneca set out industry’s priorities and the UK Office for Life Sciences struck an optimistic tone about how the UK will lastingly improve uptake of innovation.